POZEN welcomes Clint Burrus as VP
This article was originally published in Scrip
POZEN has appointed Clint Burrus vice-president of customer development, responsible for developing and executing managed markets, trade and reimbursement strategies for POZEN. Mr Burrus most recently served as executive vice-president of managed markets, government, trade and public policy at King Pharmaceuticals, chairing the company's pricing committee and inventory management committee.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.